SEC Insider Transactions from VON ESCHENBACH ANDREW C..

Last updated: 2026-03-14 11:54 UTC | Total transactions: 8

Andrew C. von Eschenbach, a director at Bausch & Lomb Corp (BLCO), made two open market purchases of BLCO shares in the past year, totaling nearly $100,000. His most recent buy occurred on February 27, 2026. These purchases rank 2,318th among 4,983 insiders in our database, well below the average of $1.46 million per buyer and 3.29 transactions. He reported no open market sales.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
Feb. 27, 2026 Bausch & Lomb Corp $BLCO VON ESCHENBACH ANDREW C. Director A Common Shares, No Par Value 4364 $0.00 70,814.0000 354,318,198 6.57% 0.00%
Feb. 27, 2026 Bausch & Lomb Corp $BLCO VON ESCHENBACH ANDREW C. Director P Common Shares, No Par Value 4364 $18.31 66,450.0000 354,318,198 7.03% 0.00%
May 27, 2025 Bausch & Lomb Corp $BLCO VON ESCHENBACH ANDREW C. Director A Common Shares, No Par Value 20338 $0.00 62,086.0000 352,470,796 48.72% 0.01%
May 2, 2025 Bausch & Lomb Corp $BLCO VON ESCHENBACH ANDREW C. Director P Common Shares, No Par Value 1695 $11.76 41,748.0000 352,470,796 4.23% 0.00%
Aug. 13, 2024 TriSalus Life Sciences, Inc. $TLSI VON ESCHENBACH ANDREW C. Not found A Director stock option (right to buy) 15000 $0.00 15,000.0000 0 9999.99% 0.00%
Aug. 2, 2024 Bausch & Lomb Corp $BLCO VON ESCHENBACH ANDREW C. Director A Common Shares, No Par Value 14696 $0.00 40,053.0000 350,500,000 57.96% 0.00%
June 3, 2024 TriSalus Life Sciences, Inc. $TLSI VON ESCHENBACH ANDREW C. Not found G Stock Option (right to buy) 35000 $0.00 35,000.0000 0 9999.99% 0.00%
June 3, 2024 TriSalus Life Sciences, Inc. $TLSI VON ESCHENBACH ANDREW C. Not found G Stock Option (right to buy) 35000 $0.00 35,000.0000 0 50.00% 0.00%